Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives.

PURPOSE HER2 mutations are identified in approximately 2%of non-small-cell lung cancers (NSCLC). There are few data available that describe the clinical course of patients with HER2-mutated NSCLC. PATIENTS AND METHODS We retrospectively identified 65 NSCLC, diagnosed with a HER2 in-frame insertion in exon 20. We collected clinicopathologic characteristics, patients' outcomes, and treatments. Results HER2 mutation was identified in 65 (1.7%) of 3,800 patients tested and was almost an exclusive driver, except for one single case with a concomitant KRAS mutation. Our population presented with a median age of 60 years (range, 31 to 86 years), a high proportion of women (45 women v 20 men; 69%), and a high proportion of never-smokers (n= 34; 52.3%). All tumors were adenocarcinomas and 50% were stage IV at diagnosis. For these latter cases, 22 anti-human epidermal growth factor receptor 2 (HER2) treatments were administered after conventional chemotherapy in 16 patients. Subsequently, four patients experienced progressive disease, seven experienced disease stabilizations, and 11 experienced partial responses (overall response rate, 50%; disease control rate [DCR], 82%). Specifically, we observed a DCR of 93% for trastuzumab-based therapies (n = 15) and a DCR of 100% for afatinib (n = 3) but no response to other HER2-targeted drugs (n = 3). Progression-free survival for patients with HER2 therapies was 5.1 months. Median survival was of 89.6 and 22.9 months for early-stage and stage IV patients, respectively. CONCLUSION This study, the largest to date dedicated to HER2-mutated NSCLC, reinforces the importance of screening for HER2 mutations in lung adenocarcinomas and suggests the potential efficacy of HER2-targeted drugs in this population.

L'intersubjectivité en questions. Introduction

La notion d'intersubjectivité est au coeur des débats contemporains dans le champ de la psychologie. L'intersubjectivité traverse en effet les différentes approches de la psychologie, des neurosciences à la psychologie sociale, des perspectives développementales aux approches psychoaffectives de la personnalité, des contextes de l'apprentissage à ceux du soin. Cet ouvrage collectif, premier volume de la collection Actualités psychologiques, se propose de faire le point sur cette notion et d'apporter des pistes actuelles de compréhension aux enjeux de la place de l'autre et de l'altérité dans la construction du sujet. Des chercheurs de renommée internationale, de Suisse et de différents pays européens, apportent ici leur contribution, dans différents domaines de la psychologie, invitant au dialogue entre les modèles théoriques qui sous-tendent la notion d'intersubjectivité et entre les méthodologies qui permettent d'en appréhender la dynamique. Contribution exceptionnelle, cet ouvrage est à destination de tous, psychologues praticiens et professionnels de la relation, chercheurs et étudiants en psychologie ou dans des disciplines connexes. Il permet d'approcher l'intersubjectivité comme une notion tout à la fois familière et complexe, au service de la rencontre de l'autre.

Corynebacterium bovis shoulder prosthetic joint infection: the first reported case.

We report the first case of Corynebacterium bovis shoulder prosthetic joint infection. The organism was isolated from intraoperative tissue culture and from the removed prosthesis using sonication. A 2-stage exchange and 3 months of antibiotic therapy were performed. C. bovis may cause implant-associated infections, which can manifest as low-grade infection.

Sémiotique, culture et développement psychologique

Ce livre propose une perspective novatrice en psychologie qui intègre la culture à titre constitutif dans son approche du développement. Comment les productions humaines contribuent-elles au développement psychologique ? Au sens fort, comment produisent-elles le psychisme ? Et comment, en les étudiant, en saisir les développements originaux chez les sujets dans leurs contextes de production ? Les recherches présentées dans cet ouvrage portent ainsi sur les dimensions matérielles de la culture dans l'avènement et le fonctionnement du psychisme, en intégrant également le langage et d'autres dimensions idéelles de celle-ci. Les textes de cet ouvrage s'inscrivent dans un dialogue interdisciplinaire, replaçant la psychologie dans le cercle des sciences humaines et sociales, requestionnant de facto son épistémologie et ses méthodes.

L'intersubjectivité en questions : agrégat ou principe organisateur en psychologie ?

La notion d'intersubjectivité est au coeur des débats contemporains dans le champ de la psychologie. L'intersubjectivité traverse en effet les différentes approches de la psychologie, des neurosciences à la psychologie sociale, des perspectives développementales aux approches psychoaffectives de la personnalité, des contextes de l'apprentissage à ceux du soin. Cet ouvrage collectif, premier volume de la collection Actualités psychologiques, se propose de faire le point sur cette notion et d'apporter des pistes actuelles de compréhension aux enjeux de la place de l'autre et de l'altérité dans la construction du sujet. Des chercheurs de renommée internationale, de Suisse et de différents pays européens, apportent ici leur contribution, dans différents domaines de la psychologie, invitant au dialogue entre les modèles théoriques qui sous-tendent la notion d'intersubjectivité et entre les méthodologies qui permettent d'en appréhender la dynamique. Contribution exceptionnelle, cet ouvrage est à destination de tous, psychologues praticiens et professionnels de la relation, chercheurs et étudiants en psychologie ou dans des disciplines connexes. Il permet d'approcher l'intersubjectivité comme une notion tout à la fois familière et complexe, au service de la rencontre de l'autre.

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.

BACKGROUND: Platinum-based doublet chemotherapy is recommended to treat advanced non-small-cell lung cancer (NSCLC) in fit, non-elderly adults, but monotherapy is recommended for patients older than 70 years. We compared a carboplatin and paclitaxel doublet chemotherapy regimen with monotherapy in elderly patients with advanced NSCLC. METHODS: In this multicentre, open-label, phase 3, randomised trial we recruited patients aged 70-89 years with locally advanced or metastatic NSCLC and WHO performance status scores of 0-2. Patients received either four cycles (3 weeks on treatment, 1 week off treatment) of carboplatin (on day 1) plus paclitaxel (on days 1, 8, and 15) or five cycles (2 weeks on treatment, 1 week off treatment) of vinorelbine or gemcitabine monotherapy. Randomisation was done centrally with the minimisation method. The primary endpoint was overall survival, and analysis was done by intention to treat. This trial is registered, number NCT00298415. FINDINGS: 451 patients were enrolled. 226 were randomly assigned monotherapy and 225 doublet chemotherapy. Median age was 77 years and median follow-up was 30.3 months (range 8.6-45.2). Median overall survival was 10.3 months for doublet chemotherapy and 6.2 months for monotherapy (hazard ratio 0.64, 95% CI 0.52-0.78; p<0.0001); 1-year survival was 44.5% (95% CI 37.9-50.9) and 25.4% (19.9-31.3), respectively. Toxic effects were more frequent in the doublet chemotherapy group than in the monotherapy group (most frequent, decreased neutrophil count (108 [48.4%] vs 28 [12.4%]; asthenia 23 [10.3%] vs 13 [5.8%]). INTERPRETATION: Despite increased toxic effects, platinum-based doublet chemotherapy was associated with survival benefits compared with vinorelbine or gemcitabine monotherapy in elderly patients with NSCLC. We feel that the current treatment paradigm for these patients should be reconsidered. FUNDING: Intergroupe Francophone de Cancérologie Thoracique, Institut National du Cancer.

Can the impact of bed closure in intensive care units be reliably monitored?

OBJECTIVE: To assess the properties of various indicators aimed at monitoring the impact on the activity and patient outcome of a bed closure in a surgical intensive care unit (ICU). DESIGN: Comparison before and after the intervention. SETTING: A surgical ICU at a university hospital. PATIENTS: All patients admitted to the unit over two periods of 10 months. INTERVENTION: Closure of one bed out of 17. MEASUREMENTS AND RESULTS: Activity and outcome indicators in the ICU and the structures upstream from it (emergency department, operative theater, recovery room) and downstream from it (intermediate care units). After the bed closure, the monthly medians of admitted patients and ICU hospital days increased from 107 (interquartile range 94-112) to 113 (106-121, P=0.07) and from 360 (325-443) to 395 (345-436, P=0.48), respectively, along with the linear trend observed in our institution. All indicators of workload, patient severity, and outcome remained stable except for SAPS II score, emergency admissions, and ICU readmissions, which increased not only transiently but also on a mid-term basis (10 months), indicating that the process of patient care delivery was no longer predictable. CONCLUSIONS: Health care systems, including ICUs, are extraordinary flexible, and can adapt to multiple external constraints without altering commonly used activity and outcome indicators. It is therefore necessary to set up multiple indicators to be able to reliably monitor the impact of external interventions and intervene rapidly when the system is no longer under control.